Myocardial infarction and use of low-dose oral contraceptives: A pooled analysis of 2 US studies

Circulation

Volumn 98, Issue 11, 1998, Pages 1058-1063

  Sidney, Stephen ^a   Siscovick, David S ^b,c   Petitti, Diana B ^d   Schwartz, Stephen M ^b,c   Quesenberry, Charles P ^a   Psaty, Bruce M ^b,c   Raghunathan, Trivellore E ^c,f   Kelaghan, Joseph ^e   Koepsell, Thomas D ^b,c  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d KAISER PERMANENTE   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Epidemiology; Myocardial infarction; Risk factors; Women

Indexed keywords

NORETHISTERONE; NORGESTREL;

ADULT; ARTICLE; CORONARY RISK; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0032530157     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.11.1058     Document Type: Article

References (23)

1. Mann JI, Vessey MP, Thorogood M, Doll R. Myocardial infarction in young women with special reference to oral contraceptive practice. BMJ. 1975;2:241-245.
2. Mann JI, Inman WHW. Oral contraceptives and death from myocardial infarction. BMJ. 1975;2:245-248.
3. Jick H, Dinan B, Rothman KJ. Oral contraceptives and nonfatal myocardial infarction. JAMA. 1978;239:1403-1406.
4. Rosenberg L, Hennekens CH, Rosner B, Belanger C, Rothman KJ, Speizer FE. Oral contraceptive use in relation to nonfatal myocardial infarction. Am J Epidemiol. 1980;111:59-66.
5. Slone D, Shapiro S, Kaufman DW, Rosenberg L, Miettinen OS, Stolley PD. Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. N Engl J Med. 1981;305:420-424.
6. Adam SA, Thorogood M, Mann JI. Oral contraception and myocardial infarction revisited: the effects of new preparations and prescribing patterns. Br J Obstet Gynaecol. 1981;88:838-845.
7. Inman WHW, Vessey MP. Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age. BMJ. 1968;2:193-199.
8. Vessey MP, Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease: a further report. BMJ. 1969;2:651-657.
9. Maguire MG, Tonascia J, Sartwell PE, Stolley PD, Tockman MS. Increased risk of thrombosis due to oral contraceptives: a further report. Am J Epidemiol. 1979;110:188-195.
10. Krueger DE, Ellenberg SS, Bloom S, Calkins BM, Maliza C, Nolan DC, Phillips R, Rios JC, Rosin I, Shekelle RB, Spector KM, Stadel BV, Stolley PD, Terris M. Fatal myocardial infarction and the role of oral contraceptives. Am J Epidemiol. 1980:111:655-674.
11. Rosenberg L, Palmer JR, Lesko SM, Shapiro S. Oral contraceptive use and the risk of myocardial infarction. Am J Epidemiol. 1990;131:1009-1016.
12. Croft P, Hannaford PC. Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study. BMJ. 1989;298:165-168.
13. Thorogood M, Mann J, Murphy M, Vessey M. Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Br J Obstet Gynaecol. 1991;98:1245-1253.
14. D'Avanzo B, La Vecchia C, Negri E, Parazzini F, Franceschi S. Oral contraceptive use and risk of myocardial infarction: an Italian case-control study. J Epidemiol Community Health. 1994;48: 324-325.
15. Sidney S, Petitti DB, Quesenberry CP Jr, Klatsky AL, Ziel HK, Wolf S. Myocardial infarction in users of low-dose oral contraceptives. Obstet Gynecol. 1996;88:939-944.
16. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. Lancet. 1997;349:1202-1209.
17. Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases, N Engl J Med. 1988;319:1313-1317.
18. Ives DG, Fitzpatrick AL, Bild DE, Psaty BM, Kuller LH, Crowley PM, Cruise RG, Theroux S. Surveillance and ascertainment of cardiovascular events: the Cardiovascular Health Study. Ann Epidemiol. 1995;5: 278-285.
19. Moreno V, Martin ML, Bosch FX, Sanjose S, Torres F, Munoz N. Combined analysis of matched and unmatched case-control studies: comparison of risk estimates from different studies. Am J Epidemiol. 1996; 143:293-299.
20. Abtech Systems. The GAUSS System Version 3.1. Maple Valley, Wash: Abtech Systems. 1992.
21. Stadel BV. Oral contraceptives and cardiovascular disease. N Engl J Med. 1981;305:612-618, 672-677.
22. Godsland I, Crook D, Wynn V. Coronary heart disease risk markers in users of low-dose oral contraceptives. J Reprod Med. 1991;36(suppl): 226-237.
23. Rosenberg L, Kaufman DW, Helmrich SP, Miller DR, Stolley PD, Shapiro S. Myocardial infarction and cigarette smoking in women younger than 50 years of age. JAMA. 1985;253:2965-2969.